Age at type 1 diabetes onset: a new risk factor and call for focused treatment.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Clinical Validation of Type 1 Diabetes Coding in Hospital Discharge Records Using ADA Criteria: Implications for Spanish and European Health Data Spaces.Journal of clinical medicine · 2026
   Article
2. Recent advances in early diagnosis and treatment of T1D with miRNAs.Frontiers in endocrinology · 2025
   Review
3. The relationship between schizophrenia or schizoaffective disorder and type 1 diabetes mellitus: a scoping review of observational studies.Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2024
   Article
4. Advances in risk predictive performance of pre-symptomatic type 1 diabetes via the multiplex Antibody-Detection-by-Agglutination-PCR assay.Frontiers in endocrinology · 2024
   Article
5. Sarcopenia: Molecular regulatory network for loss of muscle mass and function.Frontiers in nutrition · 2023
   Review
6. Differences in retinopathy prevalence and associated risk factors across 11 countries in three continents: A cross-sectional study of 156,090 children and adolescents with type 1 diabetes.Pediatric diabetes · 2022
   Article
7. Annona muricata L. peel extract inhibits carbohydrate metabolizing enzymes and reduces pancreatic β-cells, inflammation, and apoptosis via upregulation of PI3K/AKT genes.PloS one · 2022
   Article
8. Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes.Frontiers in pediatrics · 2021
   Review
9. Diabetes Technology and Therapy in the Pediatric Age Group.Diabetes technology & therapeutics · 2019
   Review

Corrections and comments

• Comment on
  Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study.2018

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as